MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Contrasting Olfactory Perception in Parkinson’s Disease: Impact of GBA1 Gene Mutations

    Y. Schechter, M. Dominko, M. Cohen, G. Yahalom, A. Zimran, S. Revel-Vilk, E. Shulman, T. Dinur, M. Becker Cohen (jerusalem, Israel)

    Objective: To investigate the role of the GBA mutation in smelling perception in PD patients and healthy subjects. Background: Hyposmia is a non-specific sign associated…
  • 2024 International Congress

    Episodes of Hypoglycemia in Patients with Parkinson’s Disease – Results of Two-Week Continuous Glucose Monitoring

    T. Chmiela, A. Gorzkowska (Katowice, Poland)

    Objective: The study aimed to determine the incidence of hypoglycemic episodes in patients with Parkinson's disease (PD) and assess risk factors for these episodes. Background:…
  • 2024 International Congress

    Prospective and Controlled Glucocerebrosidase-related Parkinson’s Disease Evaluation of Non-Motor Symptoms (PROGENS-PD)

    I. Muro, L. López-Manzanares, P. Lorenzo, E. Casas, B. González, J. Masabanda, A. Arroyo, A. Hurtado, JP. Romero (Madrid, Spain)

    Objective: To outline the protocol for an upcoming study aimed at describing the non-motor symptoms (NMS) in Parkinson’s disease (PD) patients with heterozygous glucocerebrosidase (GBA)…
  • 2024 International Congress

    Nutritional Status Implication at 6 Months in Parkinson’s Disease: Follow-Up Results

    N. Ayo Mentxakatorre, B. Tijero, T. Fernandez-Valle, A. Ortiz-de-Echevarria, M. Acera Gil, I. Chavarri Rubio, C. Juanes Moreno, M. Ruiz-Lopez, JC. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)

    Objective: To analyze the relationship between nutritional status and weight in 3 groups of patients with Parkinson's disease (PD) who are receiving different pharmacological therapies…
  • 2024 International Congress

    The Association of Pain with motor symptom severity in Parkinson’s Disease: A secondary data analysis

    N. Pacheco-Barrios, V. Gagliardi, R. Grudtner, I. Njokanma, K. Acurio, J. Rolston, B. Illigens, F. Fregni, K. Pacheco-Barrios (Boston, USA)

    Objective: This study investigates the association between pain and motor symptom severity (MSS) in PD patients. Background: Parkinson's Disease (PD) is the second most common…
  • 2024 International Congress

    Neuropathological Synergy in Cauda Equina Syndrome, Parkinson’s Disease, And Depression: Breaking the Dysphoric Cycle

    R. Grace, L. Velez, R. Islam, B. Carr (Gainesville, USA)

    Objective: This study endeavors to understand the intricate pathophysiological interactions among concurrent manifestations of cauda equina syndrome, Parkinson’s Disease (PD), and depression, with the objective…
  • 2024 International Congress

    Clinical and epidemiological profile of Parkinson’s disease in India

    A. Kishore, R. Borgohain, KP. Divya, R. Rajan, P. Pal, H. Kumar, S. Mehta, N. Kumar, LK. Prashanth, S. Desai, R. Kandadai, R. Yadav, K. Shetty, P. Wadi, A. Aggarwal, P. Agarwal, M. Abbas, G. Wali, T. Ferreira, A. Srivastava, N. Kamble, M. Divya, S. Krishnan, L. Gonzalez-Ricardo, M. Chacko, M. Sharma (Kochi, India)

    Objective: To study the clinical profile and risk factors of Parkinson’s disease (PD) in India. Background: The current knowledge of clinical and epidemiological profile of…
  • 2024 International Congress

    Exploratory Cross-Sectional Analysis of Lifestyle and Parkinson’s Disease Symptomatology

    O. Di Martino, N. Meier, S. Shafer, B. Stewart-Burger (Irvine, USA)

    Objective: This study is a cross-sectional exploratory analysis of lifestyle factors and Parkinson’s Disease (PD) symptomatology that suggests areas for targeted research into specific lifestyle…
  • 2024 International Congress

    Visuospatial-Visuoconstructive Alterations and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.

    J F. Ayala-Rico, C A. Hurtado-Gonzalez, S. Ospina-Otalvaro, J M. Márquez, L. Ortega-Bolaños, P A. Gutiérrez-Lenis, D A. Reyes-Torres, M I. Ortiz Agudelo, F. Rojas (Cali, Colombia)

    Objective: To identify whether depressive symptomatology in patients with IPDWD correlates with visuospatial and/or visuoconstructive alterations Background: Visuospatial functioning and/or visuoconstructive skills are a cognitive…
  • 2024 International Congress

    PreActive-PD Telehealth Coaching to Increase Physical Activity in Early-Stage Parkinson Disease: A Randomized Controlled Feasibility Trial

    K. Long, A. Pacheco, L. Quinn, D. Wani, J. Alomar, D. Kipnis, C. Macpherson (Walnut Creek, USA)

    Objective: To assess the feasibility/acceptability, and preliminary efficacy of Pre-Active PD intervention delivered via telehealth to increase physical activity (PA) engagement in people with early-stage…
  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • #24970 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley